Brief: CytoTools: Successful Release Of Study Drug In Europe And Start Treatment Of First Patients In Clinical Trial For Diabetic Foot Therapy
27/07/2018 10:23
July 27 (Reuters) - CYTOTOOLS AG T5OG.DE :
* ANNOUNCES SUCCESSFUL RELEASE OF STUDY DRUG IN EUROPE AND
START
TREATMENT OF FIRST PATIENTS IN CLINICAL TRIAL FOR DIABETIC FOOT
THERAPY
* FIRST RESULTS EXPECTED IN THE CONTEXT OF AN INTERIM
EVALUATION
IN EARLY 2019
Source text for Eikon: ID:nEQ8Yyr6Sa
Further company coverage: T5OG.DE
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on bioXXmed AG
See all newsBrief: CytoTools Announces Completion Of Capital Increase
Brief: CytoTools - Disputes Between CytoTools, DermaTools, Shareholders Ended
Brief: CytoTools Announces Retirement Of Two Members Of Management Board
Brief: CytoTools Sees Complete Change Of Management Board And Supervisory Board Possible
Lordstown Motors says hedge fund may buy up to $400 mln of its stock (updated)